Faculty of Chemistry, Lomonosov Moscow State University, Moscow, 119991, Russia.
Biochemistry (Mosc). 2010 Sep;75(9):1115-25. doi: 10.1134/s000629791009004x.
Here we studied the inhibition of the catalytic domain of Dnmt3a methyltransferase (Dnmt3a-CD) by DNA duplexes containing the mechanism-based inhibitor pyrimidine-2(1H)-one (P) instead of the target cytosine. It has been shown that conjugates of Dnmt3a-CD with P-DNA (DNA containing pyrimidine-2(1H)-one) are not stable to heating at 65°C in 0.1% SDS. The yield of covalent intermediate increases in the presence of the regulatory factor Dnmt3L. The importance of the DNA minor groove for covalent intermediate formation during the methylation reaction catalyzed by Dnmt3a-CD has been revealed. P-DNA was shown to inhibit Dnmt3a-CD; the IC(50) is 830 nM. The competitive mechanism of inhibition of Dnmt3a-CD by P-DNA has been elucidated. It is suggested that therapeutic effect of zebularine could be achieved by inhibition of not only Dnmt1 but also Dnmt3a.
在这里,我们研究了含有基于机制的抑制剂嘧啶-2(1H)-酮(P)而不是靶标胞嘧啶的 DNA 双链体对 Dnmt3a 甲基转移酶(Dnmt3a-CD)催化结构域的抑制作用。已经表明,Dnmt3a-CD 与 P-DNA(含有嘧啶-2(1H)-酮的 DNA)的缀合物在 65°C 加热时在 0.1%SDS 中不稳定。在调节因子 Dnmt3L 的存在下,共价中间体的产率增加。在 Dnmt3a-CD 催化的甲基化反应过程中,已经揭示了 DNA 小沟对于形成共价中间体的重要性。已经表明 P-DNA 抑制 Dnmt3a-CD;IC50 为 830 nM。已经阐明了 P-DNA 对 Dnmt3a-CD 的竞争性抑制机制。有人建议,扎布拉丁不仅可以通过抑制 Dnmt1,还可以通过抑制 Dnmt3a 来实现治疗效果。